Edetate Calcium Disodium (Edetate Calcium Disodium) Patent Expiration, LOE Window & CMS Spending

Edetate Calcium Disodium (Edetate Calcium Disodium) by Rising: Multi-Source Generic Molecule, 0 AB generics, $3.6M 2024 CMS Part D & Medicaid spend, and $32,609 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorRising
FDA Application & PathwayReconciled (ANDA)
Exclusivity / Cliff HorizonMulti-Source Generic Molecule
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$3.6M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$3.6M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($32,609 intro WAC)